DISCOVER
User Support
User support
is available in both
French
and english
This service falls within the scope of the ISO 9001 quality management system. Under the applicable contractual conditions, it participates in the Service Level Agreement.
The service is provided by our operational teams (levels 1 and 2) and technical teams (level 3).
Access H24
via the WEB Portal
Please address your support requests via the WEB portal. You must have an access account.
Connexion
If you do not have an access account:
Request an access account
Email: hotline@tentelemed.io
Hotline
You can also access support via the hotline service.
Call number:
Unless it is specified in the contract, the hotline is available during business hours: 9.30 a.m. – 6 p.m. (Paris – GMT+1)
Remote call-out
Our hotliners have a commercial platform allowing, with the authorisation of the user, remote
Access requestto the “hotline” portal
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
May 27, 2025
28 May 2025 – 04:00 PM to 05:00 PM CET (Webinar) Yoanni Th. Matsakis, President of Telemedicine Technologies, attends the first xShare webinar on the EHDS Adoption Kit for citizens. The event introduces the European Health Data Space (EHDS) and the European Electronic Health Record Exchange Format (EEHRxF). It explores data-driven healthcare through “The Health […]
May 27, 2025
Med City News Artificial intelligence is being incorporated into more places in healthcare, for uses such as guiding clinical trial enrollment as well as helping physicians get up to speed on a patient’s history. A panel discussed these applications and more during MedCity News’s INVEST conference in Chicago. In the life sciences community, there’s a […]
May 27, 2025
Applied Clinical Trials Online The need for unified, digital-first pharmacovigilance Diverse data sources and a global pharmacovigilance (PV) market mean we need to urgently adopt new, unified approaches to PV. At the same time, patient centricity, an increase in support programs, complex medicines, combination products, as well as the rise of personalized medicine are all […]